ONE System - Two Components

The INTERCEPT Blood System allows you to efficiently control the safety of your platelets and plasma by implementing pathogen inactivation technology right in your own blood center or hospital blood bank.

Efficient and flexible processing

ONE Illumination device. ONE process. ONE active compound.

INTERCEPT is designed for high throughput processing of platelets and plasma from whole blood and apheresis collections (up to 40 units/hour/illuminator).

Learn more:

Broad range of inactivation

INTERCEPT has approved pathogen inactivation claims >5 logs for a broad range of viruses (enveloped and non-enveloped), bacteria and protozoa (intracellular and extracellular), as well as leukocytes.

Learn more:

Technical data sheets

Proven safety and efficacy

The safety and efficacy of INTERCEPT treated platelets and plasma have been proven in routine use in blood centers throughout Europe and supplemented with an extensive hemovigilance program.

Learn more:

© 2012 Cerus Corporation. All Rights Reserved.

Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma. No pathogen inactivation system has been shown to inactivate all pathogens.

Legal Info | Privacy Policy